SP1 and acute myeloid leukemia: ID1 can compete with Sp1 for combining to the SIM domain of RNF4 to inhibit Sp1 degradation, thus promoting the transcription and translation of angiopoietin-like protein 7 (ANGPTL7) and AML progression.